Evidence map›Paper›PMID 39771508›Full record

ArticlePharmaceutics2024

Organic Moiety on Sn(IV) Does Matter for In Vitro Mode of Action:

Marijana P Kasalović, Sanja Jelača, Dušan Dimić, Danijela Maksimović-Ivanić, Verica V Jevtić, Sanja Mijatović, Tobias Rüffer, Goran N Kaluđerović, Nebojša Đ Pantelić

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marijana P KasalovićDepartment of Engineering and Natural Sciences, University of Applied Sciences Merseburg, Eberhard-Leibnitz-Straße 2, 06217 Merseburg, Germany.
Sanja JelačaDepartment of Immunology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11108 Belgrade, Serbia.ORCID 0000-0002-9848-6859
Dušan DimićFaculty of Physical Chemistry, University of Belgrade, Studentski Trg 12-16, 11000 Belgrade, Serbia.ORCID 0000-0001-8127-5396
Danijela Maksimović-IvanićDepartment of Immunology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11108 Belgrade, Serbia.ORCID 0000-0002-8006-5079
Verica V JevtićDepartment of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia.ORCID 0000-0001-5695-8152
Sanja MijatovićDepartment of Immunology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11108 Belgrade, Serbia.ORCID 0000-0001-9509-9098
Tobias RüfferInstitute of Chemistry, Chemnitz University of Technology, Straße der Nationen 62, 09111 Chemnitz, Germany.
Goran N KaluđerovićDepartment of Engineering and Natural Sciences, University of Applied Sciences Merseburg, Eberhard-Leibnitz-Straße 2, 06217 Merseburg, Germany.ORCID 0000-0001-5168-1000
Nebojša Đ PantelićDepartment of Chemistry and Biochemistry, Faculty of Agriculture, University of Belgrade, Nemanjina 6, 11080 Belgrade, Serbia.ORCID 0000-0003-1843-9890

Funding

German Academic Exchange Service DAAD PPP 57656312Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-65/2024-03/200116, 451-03-65/2024-03/200146 and 451-03-66/2024-03/200007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

2-quinolonesapoptosisBSA interactionsin vitro cytotoxicitymolecular dockingtributyltin(IV) compounds

Identifiers

PMID39771508
PMCPMC11679857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.